title: Drake Chemical Workers' Health Registry Study: I. Notification and medical surveillance of a group of workers at high risk of developing bladder cancer.
abstract: A medical surveillance program and epidemiologic study of 408 former workers of the Drake Chemical Company (now a Superfund waste site) was established in 1986. The Drake Health Registry Study was initiated because these workers had probable past exposures to beta-naphthylamine (BNA), a potent bladder carcinogen. The registry is widely viewed as a model for notification of workers at high risk of disease due to past occupational exposures. By the 40th month, 90% of the 366 living workers had been notified of the existence of the registry; 262 had been enrolled in the annual or semi-annual screening for bladder cancer. Among these, 27 persons have had abnormal screening results indicating moderate to high risk of bladder cancer and have been made eligible for further diagnostic tests. While no invasive bladder tumors were found among 18 persons completing the extended diagnostic evaluation, two diagnoses of moderate to severe dysplasia have been made. The registry has also identified three living and three deceased cases of bladder cancer in the cohort; a mortality analysis showed a 20- to 30-fold excess of bladder cancer. An incidence projection, based on the six identified cases, reveals that between six and ten new bladder cancer cases are likely to occur among the Drake cohort over the next 20 year period.
authors.affiliation: Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, PA 15261.
authors.forename: G M
authors.initials: GM
authors.lastname: Marsh
authors.forename: L C
authors.initials: LC
authors.lastname: Leviton
authors.forename: E O
authors.initials: EO
authors.lastname: Talbott
authors.forename: C
authors.initials: C
authors.lastname: Callahan
authors.forename: D
authors.initials: D
authors.lastname: Pavlock
authors.forename: G
authors.initials: G
authors.lastname: Hemstreet
authors.forename: J N
authors.initials: JN
authors.lastname: Logue
authors.forename: J
authors.initials: J
authors.lastname: Fox
authors.forename: P
authors.initials: P
authors.lastname: Schulte
mesh_terms: D015081:2-Naphthylamine / Q000009:adverse effects; D000328:Adult; D002423:Cause of Death; D002617:Chemical Industry; D015331:Cohort Studies; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D009784:Occupational Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology* / Q000401:mortality; D016273:Occupational Exposure / Q000706:statistics & numerical data; D010414:Pennsylvania / Q000453:epidemiology; D011159:Population Surveillance; D015995:Prevalence; D012042:Registries; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology* / Q000401:mortality
chemical_list: D015081:2-Naphthylamine